Make your money go further for just 25p per day

Not so wacky, but still unusual!

21/10/2021 · Alumasc (ALU) · Celebrus Technologies (CLBS) · Solid State (SOLI) · Synairgen · System1 (SYS1) · Tatton Asset Management (TAM)

AIM AIM Inheritance Tax potential UK

A new strategy appears to be delivering for an unusual business covered here. Elsewhere, a small AIM company developing a drug to treat Covid received positive news, but it remains a bit of a binary investment call. Read on here for our thoughts on these and other updates from the fast-moving world of AIM.

Tatton Asset: doing very nicely

The latest update from Tatton Asset Management (AIM: TAM), the investment management and IFA support services business, suggests all is going well, although they didn’t provide a huge amount of informatio.

For the six months ending 30 September 2021 total assets under management increased by 20.0% or £1.797 billion to £10.787 billion, with organic growth contributing 12.8%.

Paradigm, the Group's IFA support services business, also continued to…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login

Previous article Next article

More on Alumasc

Bonkers Bargains: still trading well in a tough market

24/10/2024 · Company Insights

After a strong run over the last few months, the shares of this building products and systems…

Episode 36 of the Investor’s Champion Podcast

05/10/2024 · Podcasts

In this episode of the Investors Champion Podcast, Chris and Lee discuss intriguing investment opportunities, focusing…

More on Celebrus Technologies

Data specialist is looking good

09/07/2024 · Company Insights

The growth potential of this provider of sophisticated data solutions remains considerable as it expands around the…

Realms of ruin | Renewed vigour

27/11/2023 · Company Insights

Results and updates covered here include a promising trading update from one of AIM’s older citizens,…

More on Solid State

Ahead again and cash builds | Too big a deal | Shock warning

15/11/2024 · Company Insights

Another positive update from one of AIM’s oldest companies has brought another upgrade and lifted the…

Challenging outlooks | Reassuringly boring | Hidden value

07/11/2024 · Company Insights

News covered here includes our assessment of two small caps facing challenging markets. Elsewhere, a fast…

More on Synairgen

Not so wacky, but still unusual!

21/10/2021 · Company Insights

A new strategy appears to be delivering for an unusual business covered here. Elsewhere, a small…

Coronavirus impact: 20 July - positive news from a respiratory drug

20/07/2020 · Company Insights

Assessment of Synairgen’s drug in Covid-19 patients could signal a major breakthrough in the treatment patients.

More on System1

Excellent travel companies | More fund manager appeal

15/07/2024 · Company Insights

News covered here includes our assessment of full year results from AIM’s largest company. With a…

Episode 25 of the Investor’s Champion Podcast

06/07/2024 · Podcasts

In this episode of the Investors Champion Podcast, Chris and Lee start with a discussion on…

More on Tatton Asset Management

Outrageous remuneration | Fabulous results | Cracking bargain

14/11/2024 · Company Insights

News covered here includes our assessment of fabulous results from an AIM listed investment manager, which…

Episode 23 of the Investor’s Champion Podcast

22/06/2024 · Podcasts

In this episode of the Investors Champion podcast, institutional investors' attraction to private equity and the…

More on Alumasc

Bonkers Bargains: still trading well in a tough market

Episode 36 of the Investor’s Champion Podcast

Episode 32 of the Investor’s Champion Podcast

Episode 27 of the Investor’s Champion podcast

More on Celebrus Technologies

Data specialist is looking good

Realms of ruin | Renewed vigour

Not for the ethically minded | A big move | Record half

Bonkers Bargains | Festive Fears | Contract wins

More on Solid State

Ahead again and cash builds | Too big a deal | Shock warning

Challenging outlooks | Reassuringly boring | Hidden value

Fund raise | Excellent offering | Renewed focus

Delightful results | What’s in the NAV? | Impressive growth

More on Synairgen

Not so wacky, but still unusual!

Coronavirus impact: 20 July - positive news from a respiratory drug

Coronavirus impact: 18 June - a big day of news from Covid-19 testers

More on System1

Excellent travel companies | More fund manager appeal

Episode 25 of the Investor’s Champion Podcast

Excuses galore | Another upgrade | Valuation concerns

Not so wacky, but still unusual!

More on Tatton Asset Management

Outrageous remuneration | Fabulous results | Cracking bargain

Episode 23 of the Investor’s Champion Podcast

Stunning results | Careful with the share class | Horrendous results

More expected | Sparkling returns | Defying the gloom

Elderly challenges | Demotion | Australian boost

Bonkers Bargains: poised to recover with a new CEO

Improving returns | Questionable business models

ABOUT INVESTORS CHAMPION

Investor's Champion offers objective, incisive and forthright comment on quoted companies and personal finance. Our content addresses what we believe are the key issues in helping make your money go further.

Investor's Champion is a registered trade mark of Investors Champion Ltd. Investor's Champion Limited is a company registered in England and Wales under number 03577867 whose registered office is at c/o Cox Costello & Horne, Batchworth Lock House, 99 Church Street, Rickmansworth, WD3 1JJ.

All rights reserved. © 2007 - 2024